The HER2 status of disseminated tumor cells in the bone marrow of early breast cancer patients is independent from primary tumor and predicts higher risk of relapse

Trastuzumab decreases the incidence of clinical relapses in patients with early breast cancer presenting chemotherapy-resistant CK-19mRNA-positive circulating tumor cells: results of a randomized phase II study

(2012) V. Georgoulias et al.   ANNALS OF ONCOLOGY

Clinical implications of the detection of circulating tumor cells in breast cancer patients

(2012) Malgorzata Banys et al.   Biomarkers in Medicine

Final results of a multicenter phase II clinical trial evaluating the activity of single-agent lapatinib in patients with HER2-negative metastatic breast cancer and HER2-positive circulating tumor cells. A proof-of-concept study

(2012) Marta Pestrin et al.   BREAST CANCER RESEARCH AND TREATMENT

Trastuzumab clears HER2/neu-positive isolated tumor cells from bone marrow in primary breast cancer patients

(2011) Brigitte Rack et al.   ARCHIVES OF GYNECOLOGY AND OBSTETRICS

Bone marrow versus sentinel lymph node involvement in breast cancer: a comparison of early hematogenous and early lymphatic tumor spread

(2011) Andreas D. Hartkopf et al.   BREAST CANCER RESEARCH AND TREATMENT

Persistence of Disseminated Tumor Cells in the Bone Marrow of Breast Cancer Patients Predicts Increased Risk for Relapse--A European Pooled Analysis

(2011) W. Janni et al.   CLINICAL CANCER RESEARCH

HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial

(2010) Tanja Fehm et al.   BREAST CANCER RESEARCH AND TREATMENT

Detection and HER2 Expression of Circulating Tumor Cells: Prospective Monitoring in Breast Cancer Patients Treated in the Neoadjuvant GeparQuattro Trial

(2010) S. Riethdorf et al.   CLINICAL CANCER RESEARCH

Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009

(2009) A. Goldhirsch et al.   ANNALS OF ONCOLOGY

Micrometastases or Isolated Tumor Cells and the Outcome of Breast Cancer

(2009) Maaike de Boer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Adjuvant oral clodronate improves the overall survival of primary breast cancer patients with micrometastases to the bone marrow--a long-term follow-up

(2008) I. J. Diel et al.   ANNALS OF ONCOLOGY

Detection of occult HER2 mRNA-positive tumor cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic relevance

(2008) Stella Apostolaki et al.   BREAST CANCER RESEARCH AND TREATMENT

Lapatinib: A dual inhibitor of human epidermal growth factor receptor tyrosine kinases

(2008) P MEDINA et al.   CLINICAL THERAPEUTICS

A pan-HER approach for cancer therapy: background, current status and future development

(2008) Zhongdong Huang et al.   EXPERT OPINION ON BIOLOGICAL THERAPY